Seek Returns logo

NMR vs. PUK: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at NMR and PUK, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

Both NMR and PUK are American Depositary Receipts (ADRs). This provides U.S. investors with straightforward access to investing in these foreign-listed companies.

SymbolNMRPUK
Company NameNomura Holdings, Inc.Prudential plc
CountryJapanHong Kong
GICS SectorFinancialsFinancials
GICS IndustryCapital MarketsInsurance
Market Capitalization21.55 billion USD35.82 billion USD
ExchangeNYSENYSE
Listing DateDecember 17, 2001June 29, 2000
Security TypeADRADR

Historical Performance

This chart compares the performance of NMR and PUK by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

NMR vs. PUK: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolNMRPUK
5-Day Price Return-5.37%1.17%
13-Week Price Return11.12%14.96%
26-Week Price Return5.90%24.79%
52-Week Price Return23.08%48.18%
Month-to-Date Return-3.32%0.10%
Year-to-Date Return12.69%63.58%
10-Day Avg. Volume10.60M4.30M
3-Month Avg. Volume10.60M3.55M
3-Month Volatility23.66%19.44%
Beta1.541.41

Profitability

Return on Equity (TTM)

NMR

10.90%

Capital Markets Industry

Max
38.97%
Q3
22.24%
Median
13.52%
Q1
8.61%
Min
-4.25%

NMR’s Return on Equity of 10.90% is on par with the norm for the Capital Markets industry, indicating its profitability relative to shareholder equity is typical for the sector.

PUK

13.58%

Insurance Industry

Max
30.96%
Q3
18.76%
Median
14.22%
Q1
10.34%
Min
1.73%

PUK’s Return on Equity of 13.58% is on par with the norm for the Insurance industry, indicating its profitability relative to shareholder equity is typical for the sector.

NMR vs. PUK: A comparison of their Return on Equity (TTM) against their respective Capital Markets and Insurance industry benchmarks.

Net Profit Margin (TTM)

NMR

8.05%

Capital Markets Industry

Max
69.91%
Q3
37.24%
Median
24.30%
Q1
13.06%
Min
-15.18%

Falling into the lower quartile for the Capital Markets industry, NMR’s Net Profit Margin of 8.05% indicates weaker profitability. This means the company retains a smaller portion of each dollar in sales as profit compared to its competitors.

PUK

19.26%

Insurance Industry

Max
26.78%
Q3
14.69%
Median
9.87%
Q1
6.59%
Min
-3.51%

A Net Profit Margin of 19.26% places PUK in the upper quartile for the Insurance industry, signifying strong profitability and more effective cost management than most of its peers.

NMR vs. PUK: A comparison of their Net Profit Margin (TTM) against their respective Capital Markets and Insurance industry benchmarks.

Operating Profit Margin (TTM)

NMR

11.32%

Capital Markets Industry

Max
84.86%
Q3
47.16%
Median
32.23%
Q1
18.65%
Min
-21.87%

NMR’s Operating Profit Margin of 11.32% is in the lower quartile for the Capital Markets industry. This indicates weaker profitability from core operations, which may stem from inefficiencies or competitive pressures on pricing.

PUK

20.87%

Insurance Industry

Max
34.52%
Q3
20.17%
Median
14.46%
Q1
9.62%
Min
-2.51%

In the Insurance industry, Operating Profit Margin is often not the primary measure of operational efficiency.

NMR vs. PUK: A comparison of their Operating Profit Margin (TTM) against their respective Capital Markets and Insurance industry benchmarks.

Profitability at a Glance

SymbolNMRPUK
Return on Equity (TTM)10.90%13.58%
Return on Assets (TTM)0.65%1.28%
Net Profit Margin (TTM)8.05%19.26%
Operating Profit Margin (TTM)11.32%20.87%
Gross Profit Margin (TTM)41.95%--

Financial Strength

Current Ratio (MRQ)

NMR

0.26

Capital Markets Industry

Max
3.37
Q3
1.81
Median
1.01
Q1
0.56
Min
0.04

For the Capital Markets industry, the Current Ratio is often not the most suitable measure of short-term liquidity.

PUK

0.36

Insurance Industry

Max
2.97
Q3
1.37
Median
0.54
Q1
0.15
Min
0.00

For the Insurance industry, the Current Ratio is often not the most suitable measure of short-term liquidity.

NMR vs. PUK: A comparison of their Current Ratio (MRQ) against their respective Capital Markets and Insurance industry benchmarks.

Debt-to-Equity Ratio (MRQ)

NMR

10.28

Capital Markets Industry

Max
6.52
Q3
2.79
Median
0.96
Q1
0.28
Min
0.00

The Debt-to-Equity Ratio is often not the primary focus for assessing leverage in the Capital Markets industry.

PUK

0.27

Insurance Industry

Max
1.25
Q3
0.65
Median
0.34
Q1
0.23
Min
0.00

The Debt-to-Equity Ratio is often not the primary focus for assessing leverage in the Insurance industry.

NMR vs. PUK: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Capital Markets and Insurance industry benchmarks.

Interest Coverage Ratio (TTM)

NMR

--

Capital Markets Industry

Max
107.59
Q3
48.41
Median
10.85
Q1
4.56
Min
-36.26

The Interest Coverage Ratio is often not a primary indicator of debt servicing capacity in the Capital Markets industry.

PUK

8.97

Insurance Industry

Max
43.68
Q3
21.45
Median
9.67
Q1
3.55
Min
-5.73

The Interest Coverage Ratio is often not a primary indicator of debt servicing capacity in the Insurance industry.

NMR vs. PUK: A comparison of their Interest Coverage Ratio (TTM) against their respective Capital Markets and Insurance industry benchmarks.

Financial Strength at a Glance

SymbolNMRPUK
Current Ratio (MRQ)0.260.36
Quick Ratio (MRQ)0.260.36
Debt-to-Equity Ratio (MRQ)10.280.27
Interest Coverage Ratio (TTM)--8.97

Growth

Revenue Growth

NMR vs. PUK: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

NMR vs. PUK: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

NMR

3.52%

Capital Markets Industry

Max
9.02%
Q3
4.54%
Median
2.55%
Q1
1.27%
Min
0.00%

NMR’s Dividend Yield of 3.52% is consistent with its peers in the Capital Markets industry, providing a dividend return that is standard for its sector.

PUK

1.54%

Insurance Industry

Max
9.80%
Q3
5.18%
Median
3.58%
Q1
2.07%
Min
0.00%

PUK’s Dividend Yield of 1.54% is in the lower quartile for the Insurance industry. This suggests the company’s strategy likely favors retaining earnings for growth over providing a high dividend income.

NMR vs. PUK: A comparison of their Dividend Yield (TTM) against their respective Capital Markets and Insurance industry benchmarks.

Dividend Payout Ratio (TTM)

NMR

66.06%

Capital Markets Industry

Max
199.38%
Q3
99.28%
Median
60.67%
Q1
32.00%
Min
0.00%

NMR’s Dividend Payout Ratio of 66.06% is within the typical range for the Capital Markets industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

PUK

24.16%

Insurance Industry

Max
169.40%
Q3
85.57%
Median
53.26%
Q1
23.68%
Min
0.00%

PUK’s Dividend Payout Ratio of 24.16% is within the typical range for the Insurance industry, suggesting a balanced approach between shareholder payouts and company reinvestment.

NMR vs. PUK: A comparison of their Dividend Payout Ratio (TTM) against their respective Capital Markets and Insurance industry benchmarks.

Dividend at a Glance

SymbolNMRPUK
Dividend Yield (TTM)3.52%1.54%
Dividend Payout Ratio (TTM)66.06%24.16%

Valuation

Price-to-Earnings Ratio (TTM)

NMR

8.50

Capital Markets Industry

Max
51.69
Q3
29.42
Median
17.58
Q1
12.55
Min
5.59

In the lower quartile for the Capital Markets industry, NMR’s P/E Ratio of 8.50 suggests the stock may be undervalued compared to its peers, potentially presenting an attractive entry point for investors.

PUK

15.64

Insurance Industry

Max
30.75
Q3
18.11
Median
12.67
Q1
9.66
Min
2.87

PUK’s P/E Ratio of 15.64 is within the middle range for the Insurance industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

NMR vs. PUK: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Capital Markets and Insurance industry benchmarks.

Price-to-Sales Ratio (TTM)

NMR

0.68

Capital Markets Industry

Max
14.65
Q3
7.29
Median
4.53
Q1
2.26
Min
0.04

In the lower quartile for the Capital Markets industry, NMR’s P/S Ratio of 0.68 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

PUK

3.01

Insurance Industry

Max
3.41
Q3
1.88
Median
1.22
Q1
0.80
Min
0.23

PUK’s P/S Ratio of 3.01 is in the upper echelon for the Insurance industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.

NMR vs. PUK: A comparison of their Price-to-Sales Ratio (TTM) against their respective Capital Markets and Insurance industry benchmarks.

Price-to-Book Ratio (MRQ)

NMR

0.87

Capital Markets Industry

Max
10.83
Q3
5.12
Median
2.66
Q1
1.19
Min
0.37

NMR’s P/B Ratio of 0.87 is in the lower quartile for the Capital Markets industry. From a value investing perspective, this is favorable, as it suggests the stock is trading at a discount to its net asset value and may offer a greater margin of safety.

PUK

1.30

Insurance Industry

Max
4.57
Q3
2.56
Median
1.88
Q1
1.20
Min
0.17

PUK’s P/B Ratio of 1.30 is within the conventional range for the Insurance industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

NMR vs. PUK: A comparison of their Price-to-Book Ratio (MRQ) against their respective Capital Markets and Insurance industry benchmarks.

Valuation at a Glance

SymbolNMRPUK
Price-to-Earnings Ratio (TTM)8.5015.64
Price-to-Sales Ratio (TTM)0.683.01
Price-to-Book Ratio (MRQ)0.871.30
Price-to-Free Cash Flow Ratio (TTM)3.3510.19